Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Invested Capital (2016 - 2026)

Biomerica's Invested Capital history spans 16 years, with the latest figure at $3.3 million for Q1 2026.

  • Quarterly results put Invested Capital at $3.3 million for Q1 2026, down 40.06% from a year ago — trailing twelve months through Feb 2026 was $3.3 million (down 40.06% YoY), and the annual figure for FY2025 was $4.1 million, down 37.72%.
  • Invested Capital for Q1 2026 was $3.3 million at Biomerica, down from $4.4 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $11.7 million in Q2 2023 to a low of $3.3 million in Q1 2026.
  • The 5-year median for Invested Capital is $6.6 million (2024), against an average of $7.0 million.
  • The sharpest move saw Invested Capital soared 40.83% in 2023, then plummeted 50.35% in 2024.
  • Year by year, Invested Capital stood at $7.2 million in 2022, then grew by 29.53% to $9.4 million in 2023, then tumbled by 45.5% to $5.1 million in 2024, then decreased by 13.28% to $4.4 million in 2025, then decreased by 25.21% to $3.3 million in 2026.
  • According to Business Quant data, Invested Capital over the past three periods came in at $3.3 million, $4.4 million, and $5.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.